Le Lézard
Classified in: Health, Science and technology, Business
Subjects: CXP, AVO

CompassCare Receives Generous Support to Expand Ethical Medical Care in New York


CompassCare is looking to move into the Big Apple with some help from a fund matching program.

ROCHESTER, N.Y., Nov. 20, 2023 /PRNewswire-PRWeb/ -- CompassCare, a New York-based pro-life Medical Network, is delighted to announce a significant milestone in its mission to provide ethical medical care and comprehensive support to women facing unplanned pregnancies. Despite facing challenges, including a regrettable incident last year, CompassCare remains dedicated to supporting women and babies, emphasizing compassion and choice.

"You can give a baby the gift of a birthday! And your financial impact amassed precisely where the abortion battle is being fought, in the abortion capital of New York, can now be doubled through December 31, up to $650,000. Give at 2XImpact.life."

CompassCare recently received over half a million dollars in matching funds, setting the stage for its expansion into the heart of the American abortion capital. The organization's goal is to raise $1.2 million by December 31, 2023, to launch medical offices in Brooklyn, Queens, and the Bronx in January 2024.

New York City is known for its high abortion rates, and CompassCare aims to make a positive impact by offering alternatives and support for women. In the face of adversity, CompassCare CEO, Rev. Jim Harden, stated, "You don't catch the flack unless you are flying over the target. New York seeks to imprison women facing unplanned pregnancy in hopelessness, robbing them of the support needed to enable true choice, support that only pro-life pregnancy centers provide, for free."

Rev. Harden acknowledges the challenges pro-life groups face in New York but remains resolute in the mission. "We are more than willing to fight digital censorship, weaponization of legislation, marginalization by legacy media, and even violent pro-abortion extremists if that is what is required to continue saving women and babies from the serial malpractice and mercenary abortion empire," he said.

CompassCare invites supporters to take advantage of the generous matching funds. Donors have committed $150,000 for "#GivingTuesday" and an additional $500,000 by year-end, doubling the impact of every donation. Rev. Harden encourages pro-life individuals, saying, "You can give a baby the gift of a birthday! And your financial impact amassed precisely where the abortion battle is being fought, in the abortion capital of New York, can now be doubled through December 31, up to $650,000. Give at 2XImpact.life."

CompassCare remains committed to its mission of providing ethical medical care and support to empower women to make choices that align with their values. The organization looks forward to expanding its reach and making a positive impact in the lives of women and babies in the New York community.

CONTACT: Jerry McGlothlin at: [email protected] or 919-437-0001.

Media Contact

Gerald McGlothlin, Special Guests, 919-437-0001, [email protected], http://www.specialguests.com

SOURCE CompassCare


These press releases may also interest you

at 08:05
Anokion SA, a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, today announced additional favorable safety and efficacy data from the company's ongoing Phase 1b/2 clinical trial...

at 08:05
Xcell Biosciences Inc. (Xcellbio), an innovative technology company focused on cell and gene therapy manufacturing applications, and AmplifyBio, a rapidly growing contract development and manufacturing organization, today announced the launch of a...

at 08:05
GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, today announced upcoming presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting being held in Chicago, Illinois...

at 08:05
Kiromic BioPharma, Inc. ("Kiromic" or the "Company") announces that UPMC in Pittsburgh, Pennsylvania has been activated as the fourth clinical trial site in the Deltacel-01 Phase 1 trial evaluating Deltaceltm (KB-GDT-01), Kiromic's allogeneic,...

at 08:03
JPMA Cares, the nonprofit foundation of the juvenile products industry, announced it's launching a Safe Sleep Campaign in partnership with Cribs for Kids, First Candle, and Safe Kids Worldwide. The campaign aims to deliver easy-to-understand,...

at 08:00
MedISAO, an organization composed of members of the medical device manufacturer community dedicated to improving medical device security through education, awareness, and advocacy, announced today its endorsement by the Food and Drug Administration...



News published on and distributed by: